UPDATED Apr 14, 2024
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
J36 | US$36.45 | -1.8% | -25.9% | US$10.5b | US$44.96 | PE15.3x | E25.0% | 6.2% | ||
BN4 | S$7.16 | -1.9% | 21.4% | S$12.7b | S$8.08 | PE14.4x | E5.9% | 4.7% | ||
S63 | S$3.99 | 0% | 10.2% | S$12.4b | S$4.41 | PE21.2x | E11.6% | 4.0% | ||
C07 | S$26.90 | 9.0% | -17.1% | S$10.6b | S$27.11 | PE6.4x | E-2.8% | 6.0% | ||
BS6 | S$1.77 | -4.8% | 45.1% | S$7.0b | S$2.05 | PE9.1x | E9.3% | 3.7% | ||
S51 | S$0.081 | -3.6% | -31.4% | S$5.5b | n/a | PB0.9x | E79.0% | 0% | ||
E28 | S$1.60 | -1.2% | 45.5% | S$683.3m | S$1.78 | PE21x | E18.6% | 1.4% | ||
BEC | S$1.94 | 1.6% | 12.8% | S$532.2m | S$2.12 | PE7x | E4.7% | 8.2% | ||
F9D | S$0.95 | -0.5% | 18.6% | S$456.0m | S$1.40 | PE9.2x | E2.7% | 4.2% | ||
H22 | S$0.60 | -3.2% | -11.8% | S$448.8m | S$1.00 | PE6.9x | E7.8% | 3.3% | ||
P9D | S$0.78 | 0% | 13.1% | S$393.4m | S$1.14 | PE7.3x | E5.0% | 6.2% | ||
P52 | S$0.45 | 0% | 15.4% | S$313.6m | n/a | PE8.8x | E3.8% | 5.1% | ||
AVM | S$0.95 | 0% | 4.4% | S$299.2m | n/a | PE16.3x | n/a | 0.7% | ||
G20 | S$0.53 | 0% | -16.5% | S$256.4m | n/a | PE23x | n/a | 4.7% | ||
BTM | S$0.90 | 0% | 32.4% | S$198.2m | n/a | PE11.8x | n/a | 2.5% | ||
500 | S$0.39 | 0% | -2.5% | S$179.5m | n/a | PE15.4x | n/a | 6.0% | ||
JLB | S$0.53 | 1.0% | 5.0% | S$178.1m | n/a | PE32.1x | E38.9% | 0.2% | ||
5GD | S$0.22 | -4.3% | -42.1% | S$175.1m | n/a | PE5.3x | n/a | 0% | ||
E3B | S$0.19 | -1.1% | -8.3% | S$172.8m | n/a | PE1.3x | n/a | 3.2% | ||
J2T | S$0.30 | -10.3% | 10.9% | S$156.2m | n/a | PE5.9x | n/a | 4.9% | ||
5VS | S$0.35 | -1.4% | 36.5% | S$152.8m | n/a | PE3.9x | n/a | 7.7% | ||
MR7 | S$0.36 | 14.1% | -20.7% | S$145.9m | n/a | PE9.1x | n/a | 4.4% | ||
1J4 | S$0.34 | 0% | 11.3% | S$142.5m | n/a | PE85.1x | n/a | 0% | ||
IX2 | S$0.56 | 0.9% | -7.5% | S$140.2m | n/a | PE15.4x | n/a | 3.6% |